Arrowhead (ARWR) is up 9.0%, or $4.21 to $51.00.
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARWR:
- Arrowhead price target raised to $48 from $45 at Morgan Stanley
- Arrowhead Pharmaceuticals: Promising Growth with Redemplo Launch and Strategic Developments in Obesity Treatments
- Arrowhead Pharmaceuticals: Hold Rating Amid Redemplo Launch and Financial Stability
- Arrowhead Pharmaceuticals Reports Transformative Year-End Results
- Arrowhead reports FY25 EPS (1c), consensus (3c)